Cargando…

Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358

Recently, the clinical and experimental evidences that support the toxic effects of indoxyl sulfate, a protein-bound uremic toxin in chronic kidney disease (CKD) patients, has been discussed. In this panorama, the authors described several in vitro and in vivo studies, suggesting that indoxyl sulfat...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreto, Fellype C., Barreto, Daniela V., Stinghen, Andrea E. M., Massy, Ziad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408216/
https://www.ncbi.nlm.nih.gov/pubmed/28420181
http://dx.doi.org/10.3390/toxins9040142
_version_ 1783232262190399488
author Barreto, Fellype C.
Barreto, Daniela V.
Stinghen, Andrea E. M.
Massy, Ziad A.
author_facet Barreto, Fellype C.
Barreto, Daniela V.
Stinghen, Andrea E. M.
Massy, Ziad A.
author_sort Barreto, Fellype C.
collection PubMed
description Recently, the clinical and experimental evidences that support the toxic effects of indoxyl sulfate, a protein-bound uremic toxin in chronic kidney disease (CKD) patients, has been discussed. In this panorama, the authors described several in vitro and in vivo studies, suggesting that indoxyl sulfate may play a part in the pathogenesis of low turnover bone disease. However, the discussion claims the need for relevant clinical studies in CKD patients whose bone turnover biomarkers and bone histomorphometry were assessed in order to demonstrate the association between serum levels of indoxyl sulfate and bone turnover. We would like to underline the availability of this clinical data to support the concept that indoxyl sulfate may play a part in the pathogenesis of low turnover bone disease in CKD patients.
format Online
Article
Text
id pubmed-5408216
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-54082162017-05-03 Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358 Barreto, Fellype C. Barreto, Daniela V. Stinghen, Andrea E. M. Massy, Ziad A. Toxins (Basel) Comment Recently, the clinical and experimental evidences that support the toxic effects of indoxyl sulfate, a protein-bound uremic toxin in chronic kidney disease (CKD) patients, has been discussed. In this panorama, the authors described several in vitro and in vivo studies, suggesting that indoxyl sulfate may play a part in the pathogenesis of low turnover bone disease. However, the discussion claims the need for relevant clinical studies in CKD patients whose bone turnover biomarkers and bone histomorphometry were assessed in order to demonstrate the association between serum levels of indoxyl sulfate and bone turnover. We would like to underline the availability of this clinical data to support the concept that indoxyl sulfate may play a part in the pathogenesis of low turnover bone disease in CKD patients. MDPI 2017-04-17 /pmc/articles/PMC5408216/ /pubmed/28420181 http://dx.doi.org/10.3390/toxins9040142 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Barreto, Fellype C.
Barreto, Daniela V.
Stinghen, Andrea E. M.
Massy, Ziad A.
Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title_full Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title_fullStr Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title_full_unstemmed Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title_short Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
title_sort comment on indoxyl sulfate—review of toxicity and therapeutic strategies. toxins 2016, 8, 358
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408216/
https://www.ncbi.nlm.nih.gov/pubmed/28420181
http://dx.doi.org/10.3390/toxins9040142
work_keys_str_mv AT barretofellypec commentonindoxylsulfatereviewoftoxicityandtherapeuticstrategiestoxins20168358
AT barretodanielav commentonindoxylsulfatereviewoftoxicityandtherapeuticstrategiestoxins20168358
AT stinghenandreaem commentonindoxylsulfatereviewoftoxicityandtherapeuticstrategiestoxins20168358
AT massyziada commentonindoxylsulfatereviewoftoxicityandtherapeuticstrategiestoxins20168358